T Cell Tolerance to Germline-Encoded Antibody Sequences in a Lupus
In this study, we tested whether this tolerance is intact in systemic lupus erythematosus-prone (New Zealand Black ؋ SWR)F 1 mice (SNF 1 ). Using a hybridoma sampling approach, we found that SNF 1 T cells were tolerant to germline-encoded Ab sequences. Specifically, they were tolerant to germline-encoded sequences derived from a lupus anti-chromatin Ab that arose spontaneously in this strain. This was true both for diseased and prediseased mice. Thus, there does not appear to be a global defect in T cell tolerance to Ab V regions in this autoimmune-prone strain either before or during autoimmune disease. A hallmark of systemic lupus erythematosus is the unregulated synthesis of autoreactive Abs with biologically significant affinities for self-Ags that include nuclear structures, such as chromatin, dsDNA, and ribonucleoprotein. These autoantibodies form immune complexes, which may deposit in the kidney and induce or exacerbate renal disease (1) (2) (3) (4) . Spontaneous mouse models of lupus, such as the MRL/Mp-lpr/lpr strain, and F 1 hybrids between New Zealand Black (NZB) 3 and either New Zealand White (NZW) or SWR strains have been exploited in studies to address the pathological mechanism of autoantibody production. A considerable body of evidence obtained from these animal models supports the idea that some lupus autoantibodies are products of T cell-dependent immune responses (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) . Autoantibody development can be precluded by experimental manipulations that inhibit T cell-B cell collaboration (7) (8) (9) (10) 17) . Moreover, hybridoma sampling studies have shown that lupus autoantibodies often bind autoantigens with significant avidity; they are the result of oligoclonal B cell expansion; and they are products of class switch recombination and V region gene hypermutation (6, (11) (12) (13) (14) (15) (16) .
Although there is good evidence for T cell help to autoreactive B cells in lupus, the antigenic specificity of this help has remained obscure. There is some evidence that T cell help in lupus is directed to ubiquitous self-Ag, such as chromatin or ribonuclear protein (18 -21) . More subtle self-Ag, generated by posttranslational modifications are also potential targets (22) (23) (24) . Finally, peptides from the BCR V region may provide an avenue of T cell help to autoreactive B cells. The BCR V region is promising in this regard because of the enormous diversity encompassed by V region peptides and because such peptides can be self-presented in class II MHC by activated B cells, which presumably are dependent upon T cell help (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) . We refer to this potential avenue of help to autoreactive B cells as the receptor presentation hypothesis (35) .
Several groups have reported evidence in support of receptor presentation in autoimmunity (27, 30, 31, (35) (36) (37) (38) (39) (40) . In a preceding study, we conducted a genealogical analysis of somatic mutations within an autoreactive B cell lineage obtained from a spontaneously diseased SNF 1 mouse. The results of this work implicated somatic mutations within the BCR V region in creating an avenue of help to chromatin-reactive B cells (35) . Other groups have reported more promiscuous reactions by T cells against autoantibody V regions, and in at least one case, the T cells were apparently reactive to a peptide specified by a germline-encoded stretch of DNA (41) (42) (43) . This observation suggests that T cells in autoimmune-prone mice might lose, or fail to attain, tolerance to germline-encoded Ab sequences.
Distinguishing between T cell help via germline-encoded vs somatically generated Ab sequences is important because of concentration and temporal considerations. Compared with somatically generated sequences, germline-encoded sequences are more abundant, both during T cell development in the thymus and activation in the periphery. More importantly, somatic hypermutation of Ab V regions in mice and humans occurs primarily in the germinal center at a late stage of development in rare Ag-selected B cells (44 -50) . Although previous studies have indicated that T cells in normal mice are tolerant with respect to germline-encoded Ab diversity (26, 32, 33) , this issue has not been explicitly addressed in lupus-prone mice. In this report, we provide evidence that lupusprone SNF 1 mice attain tolerance to germline-encoded Ab diversity and that this state is apparently maintained in diseased animals.
H2B/dsDNA mAb with two known V H somatic mutations that produce amino acid replacements. This Ab was derived from a spontaneously diseased female SNF 1 mouse (12) . SN5-18R is a germline-reverted version of mAb SN5-18, in which the two somatic mutations were converted to the germline sequence of the corresponding NZB V H gene (35) . Twenty-nine overlapping 15-mer peptides encompassing the entire amino acid sequence of mAb SN5-18R V H , excluding the third CDR (CDR3), were synthesized by Mimotopes. Each peptide overlapped its neighbor by 12 aa. A mutated framework 1 (FR1) peptide spanning the residue 28 replacement mutation in mAb SN5-18 and three CDR3 peptides were also synthesized by the Molecular Resource Center (National Jewish Medical and Research Center). Their sequences and locations within the V H region are listed in Table I .
Purification of Abs
Abs were purified as described previously (35) . Culture supernatants were passed through protein G columns, and mAb were eluted with a 0.5 M NaCl/0.1 M glycine (pH 2.5) solution and dialyzed against PBS. The crude mAb were treated with DNase (1 g/ml; Worthington Biochemical) in the presence of 2 mM MgCl 2 at 37°C for 90 min. This material was then passed through a Sepharose column conjugated with affinity-purified goat anti-mouse IgG (heavy and L chain specific; Zymed Laboratories). High salt solution (1.5 M NaCl in PBS (pH 7.2)) was then passed through the column to dissociate any histones associated with the bound mAb, which was subsequently eluted with 0.5 M NaCl/0.1 M glycine (pH 2.5) and dialyzed extensively against PBS. Ab purity was assessed by SDS-PAGE.
Production of T cell hybridomas
T cell hybridomas were produced as described previously (33) . Briefly, SWR and SNF 1 mice were immunized s.c. with 100 l of whole mAb (100 g) emulsified in CFA (Difco Laboratories). Mice were sacrificed 7 days following immunization, and draining lymph node cells were cultured 3 days with mAb (125 g/ml) followed by a 3-day culture with IL-2 before polyethylene glycol-induced cell fusion to the BW5147 thymoma (TCR␣ Ϫ ␤ Ϫ ) as described previously (33) . T cell hybridomas were screened for IL-2 production in response to APC cultured with the mAb or peptide immunogens. In most assays, 10 5 T cells were cocultured overnight with 3 ϫ 10 5 APC and Ag at a final concentration of 62.5 g/ml for Ab or 2.5 g/ml for peptide. A time-resolved fluoroimmunometric assay was used to measure IL-2 as described previously (29) . For MHC restriction studies, NZB and SWR splenocytes were used as APC.
Southern blot
To determine whether SWR mice contain the germline V H gene encoding mAb SN5-18R, SWR and NZB genomic kidney DNA was digested separately with BamHI, BglII, and EcoRI, and analyzed in Southern blot with a 135-bp V H probe spanning codons 22-66 of the corresponding germline NZB V H gene (35) . A 387-bp J H probe was used as a positive control for DNA integrity. Hybridizations were done at 42°C in 10 ml of a solution containing 8 ϫ 10 7 cpm of PCR-labeled probe, 5ϫ SSC, 10% dextran sulfate, 5ϫ Denhardt's solution, 500 g/ml ssDNA, 1% SDS, and 50% formamide. Initial washes were performed in 50 ml of a solution containing 50% formamide, 0.4% SDS, and 5ϫ SSC at 42°C for 1 h; and stringency washes were done at 47°C in 50 ml of a solution containing 2ϫ SSC, 0.4% SDS, and 50% formamide (20 min). The membrane was wrapped and exposed for 4 h on phosphoimager film, then signals were read in Typhoon 9200 Variable Mode Imager (Amersham Biosciences).
Sequencing the SWR V 10.2b gene
To determine whether SWR mice carry a germline V gene matching the sequence of the V 10.2b of mAb SN5-18R, SWR genomic DNA was subjected to PCR amplification with primers corresponding to a sequence located 70 bases upstream of the leader exon and to the 3Ј end of the V 10.2b gene expressed by mAb SN5-18R: 5Ј primer, GCA TGC TCT CAC TTC CTA TCT TTG; and 3Ј primer, GCT TAC TAT ACT GCT GAC AAT AG. Thirty PCR cycles were performed with high-fidelity DNA polymerase (Phusion; MJ Bioworks) as follows: 94°C, 30 s; 62°C, 1 min; and 72°C, 1 min. Following Taq-mediated addition of 3Ј A bases, the PCR products were inserted into a TOPO TA Cloning vector (Invitrogen Life Technologies) for sequencing with vector primers, according the manufacturer's 
protocol. DNA sequencing was performed by the National Jewish Molecular Resource Center.
Binding assays of serum autoantibodies
Anti-chromatin Ab were detected in a fluoroimmunometric assay by coating 96-well microtiter plates with mouse chromatin (10 g/ml). After incubating with a blocking buffer (2% BSA, and 1% gelatin in PBS), dilutions of SNF 1 sera were added to the plates for 1 h. IgG anti-chromatin Ab were detected with a biotin-labeled rat anti-mouse IgG (Southern Biotechnology Associates) followed by a streptavidin-Eu 3ϩ conjugate. Europium fluorescence was measured at 615 nm on a Wallac Victor (PerkinElmer Wallac) as described previously (29) . Anti-Smith Ag (Sm) Ab and anticardiolipin Ab were identified similarly, except that plates were coated with 10 g/ml calf thymus Sm (ImmunoVision) or bovine cardiolipin (10 g/ml; Sigma-Aldrich).
Histology
For immunohistology, one of the kidneys was removed and embedded in Cyromolds (Miles) filled with Optimal Cutting Temperature compound (Sakura Finetek). Serial sections (5-7 m) were cut at Ϫ16°C and placed on microscope slides. Tissues were fixed by submerging slides in acetone (5 min), air-dried, and stored at Ϫ80°C. Tissue samples were then thawed at room temperature (RT) and incubated at RT for 15 min with 5% normal goat serum in PBS. Fifty microliters of diluted flurochrome-labeled Abs (goat anti-mouse IgG and goat anti-mouse IgM; BD Pharmingen) were added and incubated for 30 min at RT followed by three washes with PBS. Coverslips were placed on the samples with mounting media (Biomedia) for fluorescence and sealed with nail polish. Another of the kidneys was paraffin-embedded, sliced, and stained with H&E. H&E staining was performed by the Histology Facility (National Jewish Medical and Research Center).
Results

No detectable T cell response to germline-encoded V H segment of an anti-chromatin Ab
Prior results from our laboratory indicated that tolerance to germline-encoded V region peptides is attained by CD4 ϩ T cells in nonautoimmune-prone mice (32) . In this study, we tested whether autoimmune-prone SNF 1 mice were self-tolerant to a germlineencoded autoantibody, specifically one reactive with chromatin (H2A/H2B/DNA). As in our preceding study, tolerance/responsiveness was assessed using a T cell hybridoma readout (32) . This approach offers the advantage of enhanced definition that comes from an ability to repeatedly test hybridomas for peptide specificity, MHC-restriction, dose response, and cross-reactions. In addition, the CFA immunization and stimulations in vitro with Ag and IL-2 before fusion elicit clonal expansion of even rare, Ag-specific T cells.
Six young (8 wk old), prediseased SNF 1 mice were immunized with a germline version of a spontaneous anti-chromatin Ab (mAb SN5-18R). The original mAb (SN5-18), containing two replacement somatic mutations in the V H 7183 region, was derived from an autoimmune SNF 1 female mouse (12) . In mAb SN5-18R, these mutations were reverted to germline sequence, and the V gene was expressed in the context of a BALB/c ␥2b constant gene (35, 52) . The L chain of mAb SN5-18R (V 10.2b -J1) contains no somatic mutations (12) .
From these cell fusions, we screened 261 T hybridomas for those that produced IL-2 in response to mAb SN5-18R in the context of SNF 1 splenic APCs. Twenty-six hybridomas, some for each mouse, reacted with the IgG2b constant region, which contains an allotypic T cell epitope encoded by the BALB/c ␥2b gene. Other T cell hybridomas responded spontaneously to SNF 1 APC without Table III ). deliberately added Ag. Representative data are shown in Fig. 1A . In all, only seven hybridomas responded to the V H /D/J H region of mAb SN5-18R. However, in additional tests, we found that all seven of these reacted to a pair of CDR3 peptides spanning the V H -D boundary (Fig. 1B) . No T cell hybridoma reacted to strictly germline-specified peptides. Table II summarizes the results of the T cell hybridoma analysis. Collectively, these results indicate that the germline-encoded sequences within the anti-chromatin Ab were not immunogenic in SNF 1 mice.
T cell response in parental SWR mice to germline-encoded V H sequences of an anti-chromatin Ab
A lack of immunogenicity could be due to intrinsic properties of mAb SN5-18R. It was possible, for example, that no peptides from the V H region of this Ab could be appropriately processed and presented in the context of class II MHC. To determine whether the absence of a T cell response to mAb SN5-18R in SNF 1 mice was due to tolerance, we assessed its immunogenicity in parental SWR mice. Although we knew that the V H gene encoding this Ab was derived from the NZB parental strain, it was important in tests of tolerance to demonstrate that the SWR strain lacked this V H gene (12) . To this end, we performed a Southern blot using a DNA probe derived from the V H gene of mAb SN5-18R. In this assay, genomic DNA from NZB and SWR mice was digested separately with three restriction enzymes. With each enzyme, a single hybridization signal was detected in lanes containing NZB DNA. The signals identified DNA fragments containing a previously defined NZB V H 7183 gene used by the anti-chromatin Ab (35) . No signal was seen in any of the lanes containing SWR DNA that was hybridized with the V H probe. In contrast, single signals were seen in all lanes hybridized with a J H probe, thus confirming integrity of the digested and transferred SWR DNA. In additional tests, we were never able to amplify the corresponding V H gene from SWR genomic DNA by PCR. These results indicate that the SWR parental strain lacks the germline V H 7183 gene for mAb SN5-18R (Fig. 2) .
To determine whether mAb SN5-18R was immunogenic in SWR mice, which lack the corresponding V H gene, we generated and screened T cell hybridomas from SWR mice immunized with mAb SN5-18R as described above. This time, 52 of 291 hybridomas from four SWR mice (8 wk old) responded to the V region of the mAb (Table III) . Of 29 hybridomas that were successfully recloned, 13 responded to V H CDR3 peptides, and one responded to a VCDR-3 peptide. However, the remaining 15 responded to germline-encoded V H peptides, one of which was located in FR1 (p7 and p8), and two of which were located in CDR2 (p16 and p17 or p19). Because p16 and p19 overlap by only six residues, which are insufficient to confer binding to class II MHC, we conclude that two distinct MHC binding epitopes are present within CDR2. All of the hybridomas reacted to Ag in the context of SNF 1 or SWR APC, but not NZB APC, indicating their restriction to I-A q (data not shown). Responses to germline-specified peptides are shown in Fig. 3 .
The consistent positive response to germline-specified peptides by SWR mice, which lack the SN5-18R V H gene, in contrast to the lack of a response by SNF 1 mice, which carry this V H gene ( p Ͻ 0.0003) (Table III) , supports the hypothesis that T cells in autoimmune-prone SNF 1 mice attain a state of tolerance to germlineencoded Ab sequences. Specifically, tolerance was attained to three distinct epitopes in the V H region of a lupus autoantibody.
The absence of an SWR T cell response to the germline SN5-18R V region stood in striking contrast to a consistent V H -specific response. This could be explained if the SWR strain contained a germline V 10.1b gene identical in sequence to that encoding the L chain V region of mAb SN5-18R. If this were true, the T cell repertoire in SWR (normal) mice would be expected to attain a state of tolerance to SN5-18R Vk peptide sequences. To test this, we amplified and sequenced the V 10.2b gene from SWR genomic DNA using leader and 3Ј-most primers and found that the sequence of the SWR V gene exactly matched that of SN5-18R V . Thus, it is likely that T cells in both SWR and SNF 1 mice attain a state of tolerance to germline V 10.2b sequences.
Maintenance of T cell tolerance to germline-encoded portion of an anti-chromatin Ab in diseased SNF 1 mice
To determine whether tolerance was maintained in spontaneously autoimmune mice, we conducted immunogenicity tests as before, but this time in SNF 1 mice with manifestations of lupus-like disease. Seven 6-mo-old female mice with evidence of proteinuria a Twenty-nine of 52 V region-specific T hybriodomas were tested for responses to V region peptides. (100 mg/dl) were used in this experiment. All of these mice had high titers of serum Abs directed against chromatin and Sm, and six of them had Abs against cardiolipin (or ␤ 2 -glycoprotein 1) before immunization. Moreover, at the conclusion of the experiment, four of four mice examined exhibited diffuse glomerulonephritis with deposition of IgM and IgG, evident by immunohistology (data not shown).
The diseased mice were assessed for tolerance to mAb SN5-18-R as described above. In all, 274 T cell hybridomas were generated and tested. Fourteen of these reacted against the ␥2b constant region, and 19 reacted against the V H /D/J H region. All 19 of these latter hybridomas were specific for V H CDR3 sequences. These data, summarized in Table IV , support the idea that tolerance to germline-encoded Ab sequences is maintained, even in SNF 1 mice with active disease.
T cell reactions to a somatically mutated portion of an antichromatin Ab in SNF 1 mice
As a final positive control for immune responsiveness in SNF 1 mice and a quality control for consistency in our results, we assessed immunogenicity of the original somatically mutated SN5-18 Ab. Our previous studies had demonstrated that a threonine to isoleucine mutation at residue 28 in V H FR1 of this Ab produced a T cell epitope restricted by I-A q . This mutation was found in all members of an autoreactive lineage represented by seven B cell hybridomas, and provided the foundation of the receptor presentation hypothesis (35) . From four SNF 1 mice (8 wk old) immunized with mAbSN5-18, we screened 100 T cell hybridomas. Two hybridomas responded to the ␥2b allotypic determinant; seven responded to V H CDR3 sequences, and six responded to the mutant FR1 sequence in a dose-dependent manner (Table V and Fig. 4) . Importantly, the latter six hybridomas all required the Thr to Ile mutation for their responses, and they were restricted by SWR APC (I-A q ).
Discussion
There is a growing body of evidence that peptides from the BCR V region may provide an avenue of CD4 ϩ T cell help for autoreactive B cells (27, 28, 30, 31, 35, 38 -42) . Much of the evidence for this receptor presentation idea comes from studies performed in (NZB ϫ NZW)F 1 and (NZB ϫ SWR)F 1 mice (SNF 1 ), which develop an age-dependent systemic autoimmune disease, with many of the hallmarks of human lupus (27, 31, 35) . Testing the receptor presentation idea is complex, in part because of the diversity within Ab V regions. The diversity arises from both germline sequences and two fundamentally distinct somatic processes that occur at different points in B cell development. Results of previous studies have indicated that normal mice attain a state of tolerance to germline-encoded Ab diversity (25, 26, 32, 33) . In this study, we tested whether lupus-prone SNF 1 mice exhibit a global deficiency in such tolerance. Our results support the idea that tolerance to germline-encoded Ab sequences is intact in SNF 1 mice and apparently maintained, even in diseased animals. a p Ͻ 0.0002 that none of the mice would yield germline peptide-specific hybridomas by chance alone given the frequencies of such hybridomas obtained from the SWR-positive control group (Table III) .
FIGURE 3.
Responses of SWR T cell hybridomas to germline-encoded V H peptides of mAb SN5-18R. p6, p7, and p8 are FR1 peptides, and p16, p17, p18, and p19 are CDR2 peptides, as specified in Table I . A, T cell hybridomas respond to a FR1 epitope (p7 and p8). B, T cell hybridomas respond to two CDR2 epitopes (p16 and p17 or p19). Error bars indicate SDs.
We tested for tolerance by performing immunizations with an intact unmutated Ab, generating T cell hybridomas and testing these for reactivity to the Ab V regions and corresponding peptides. The test Ab was specific for chromatin and represented a germline version of an original mutated isolate derived from an autoimmune SNF 1 mouse. No T cell hybridoma reactive to germline-encoded sequences of the anti-chromatin Ab was obtained from syngeneic SNF 1 mice that were immunized either before or after developing manifestations of lupus. In contrast, they were readily obtained from parental SWR mice, which lacked the corresponding V H gene encoding this Ab. SNF 1 mice did produce hybridomas that reacted to somatically generated V H CDR3 sequences and to a somatically mutated V H FR1 sequence when immunized with the corresponding mutant Ab.
Although T cells appear to be tolerant to the SN5-18R lupus autoantibody, we cannot formally exclude the possibility that some V genes in the repertoire are expressed at inordinately low levels and that self-tolerance to these might not be efficiently attained by T cells in the repertoire. Moreover, the T cell hybridoma approach does not permit us to determine how T cell tolerance is attained. V region reactive CD4 T cells might be deleted in the thymus (53), or they might be suppressed or incapable of full differentiation in the periphery for some other reason. It is even conceivable that V region-specific T cells survive longer in autoimmune-prone SNF 1 and provide limited functions without being endowed a capacity to fully develop to a state that can be immortalized by fusion. The T cell hybridoma approach is also labor intensive. Nevertheless, we consider it a rigorous test for the presence of fully competent Agspecific T cells. CFA was used in the immunizations, and both IL-2 and Ag stimulations in vitro preceded cell fusions. Moreover, with hybridomas, it is possible to conduct repeated tests to confirm and further define response patterns, and to identify TCR gene use and construct corresponding transgenic animals (53) . In contrast, we have repeatedly found that whereas lymph node proliferation assays yield excellent results for conventional foreign proteins, they are not reliable for assessing tolerance to Ig. Even in positive control tests, specific proliferation was inconsistent and weak in the best cases. We do not know why this is so. Perhaps, tolerance to the multiple members of V region families leaves only a very low precursor frequency of T cells reactive against any specific V region.
A major reason for conducting this study derives from our previous observation that the clonal expansion of a spontaneous autoreactive B cell lineage from an SNF 1 mouse was correlated with a pair of V H somatic mutations. Although neither mutation affected the affinity of the Ab product for chromatin, one of them, a Thr to Ile mutation at residue 28, produced a class II MHC-restricted T cell epitope (35) . This mutation was shared by all seven members of the lineage, thus marking a point of massive clonal expansion.
Complementary studies of T cell proliferation in lupus-prone (NZB ϫ NZW)F 1 mice from other laboratories have also provided evidence for the receptor presentation concept (28, 30, 38, 54) . However, results of some of these studies suggest that T cells may respond more promiscuously to autoreactive Ab V regions (41, 42) . In particular, determinant spreading to multiple parts of the V region was reported to occur in aged mice with disease (42) . And at least one response pattern to a germline-specified V H peptide was noted (43) .
Although our results do not formally rule out the possibility of T cell responses to germline V sequences in murine lupus, we can conclude that if this occurs, it is not due to global defect in tolerance to germline sequences in the SNF 1 mouse. Logically, somatically mutated sequences are the most attractive candidates for avenues of T cell help to autoreactive B cells because they arise in rare B cells at a late stage of differentiation when the animal has a full repertoire of "educated" T cells. As such, somatic mutations can create neoantigens precisely within the B cell seeking T cell help and in the realm of an Ag-processing pathway that makes this possible. The idea that T cells attain a state of tolerance to germline-encoded Ab sequences has important implications to the design of idiopeptide-specific immunotherapies for autoimmunity and cancers of the lymphoid lineage (55-57). a Hybridomas responding to mutant FR1 were restricted by SWR APC.
